scorecardresearch
Add as a preferred source on Google
Monday, November 3, 2025
TopicDCGI

Topic: DCGI

After WHO alert, drug controller general warns against use of cough syrups containing pholcodine

Pholcodine is used to treat dry cough. WHO had flagged risk of anaphylactic reactions in those who took remedies containing Pholcodine at least 12 months prior to surgery.

‘1st for India’ — device made from pig gall bladder heals skin wounds like burns with few scars

Low-cost tissue-engineering scaffold Cholederm — developed by Thiruvananthapuram-based Sree Chitra Tirunal Institute for Medical Sciences & Technology — approved by DCGI.

All about Serum Institute’s HPV vaccine, India’s 1st indigenous shot against cervical cancer

Pune-based SII has got the go-ahead from the Drugs Controller General of India to market the vaccine. Cervical cancer is one of the leading causes of female cancer mortality worldwide.

DCGI approves Corbevax as first heterologous Covid booster dose for adults

A press release from Corbevax maker said it could be administered as a booster after six months of administration of primary vaccination for restricted use in emergency situation.

DCGI gives nod to Biological E’s Covid vaccine phase 2/3 clinical trials on 5-18 year olds

The trial will be conducted across 10 sites in India. Zydus Cadila's ZyCoV-D is so far the only vaccine to get Emergency Use Authorisation in the 12-18 years age group in India.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

Drug regulator says no need for bridging trials on foreign approved vaccines before India roll out

DCGI modifies earlier order on emergency approval of well-established vaccines, waives several requirements, but retains assessment of first 100 beneficiaries before proper roll out.

DCGI approves anti-Covid drug developed by DRDO for emergency use

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy's Laboratories in Hyderabad.

DCGI to take decision on emergency use applications for foreign Covid vaccines in 3 days

The DCGI will issue permission for restricted emergency use on the condition that the vaccine be used according to guidelines under the National Covid-19 Vaccination Programme.

DCGI approves Russian Covid vaccine Sputnik for restricted emergency use in India

Sputnik V is to be administered intramuscularly to individuals aged 18 yrs & above in two doses of 0.5 ml each with an interval of 21 days.

On Camera

10 years of the Commercial Courts Act—has the law delivered on its promise?

More than 60 per cent of the suits remain pending after two years of having been filed, and this proportion is agnostic to whether the suit is a commercial or ordinary suit.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.